fda drug safety podcast: fda warns about increased risk of cancer relapse with long-term use of a...
Published 3 weeks ago • 2 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
4:01
fda warns about possible increased risk of death and serious side effects with cancer drug copikt...
-
3:01
fda drug safety podcast: fda warns about increased risk of serious pancreatitis with irritable bo...
-
3:31
fda investigating possible increased risk of death with lymphoma medicine ukoniq (umbralisib)
-
3:01
fda drug safety podcast: fda review finds no significant increase in risk of serious asthma outco...
-
3:31
fda drug safety podcast: fda to evaluate potential risk of neural tube birth defects with hiv med...
-
2:01
fda withdrew its approval for the cancer medicine ukoniq (umbralisib) due to safety concerns
-
3:01
fda warns about rare occurrence of serious liver injury with use of hepatitis c medicines mavyret...
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
3:01
fda drug safety podcast: fda reinforces safety information about serious low blood sugar levels a...
-
3:01
fda drug safety podcast: fda limits packaging for anti-diarrhea medicine loperamide (imodium) to ...
-
1:30:42
conversations on cancer - cancer misinformation: truth or consequences
-
1:30
fda orders warning label on a cancer drug
-
3:21
fda d.i.s.c.o.: intro by dr. richard pazdur
-
32:23
government regulation of cancer drugs: the fda's take
-
5:15
fda d.i.s.c.o.: rucaparib in ovarian cancer
-
5:58
fda d.i.s.c.o.: niraparib in ovarian cancer transcript
-
1:58
fda approves new cancer drug that's already showing promise
-
51:51
the fda: a spoonful of safety makes the medicine go down
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of opdivo in combination with chemotherapy and opdivo...